Its Not Just Boilerplate! Best practices for drafting collaboration - - PowerPoint PPT Presentation

it s not just boilerplate
SMART_READER_LITE
LIVE PREVIEW

Its Not Just Boilerplate! Best practices for drafting collaboration - - PowerPoint PPT Presentation

MARCH 13, 2013 Its Not Just Boilerplate! Best practices for drafting collaboration agreements to protect your IP By Elizabeth A. Howard, Ph.D. & Michael C. Spillner Presenters Elizabeth A. Howard, Ph.D. Michael C. Spillner Orrick


slide-1
SLIDE 1

MARCH 13, 2013

By Elizabeth A. Howard, Ph.D. & Michael C. Spillner

It’s Not Just Boilerplate!

Best practices for drafting collaboration agreements to protect your IP

slide-2
SLIDE 2

Elizabeth A. Howard, Ph.D.

Presenters

Michael C. Spillner

  • Orrick IP partner
  • J.D., Hastings College of the Law
  • Ph.D., U.C. Berkeley, Molecular Biology
  • Orrick IP partner
  • J.D., Stanford Law School
  • B.A., UCLA

2

slide-3
SLIDE 3
  • 1. The collaboration conundrum
  • 2. The Tekmira case: a cautionary tale

Outline

  • 3. Best practices for drafting specific provisions

3

slide-4
SLIDE 4
  • 1. The collaboration conundrum
  • 2. The Tekmira case: a cautionary tale

Outline

  • 3. Best practices for drafting specific provisions

4

slide-5
SLIDE 5
  • Collaborations are for the parties’ mutual benefit,

The collaboration conundrum

Collaborations are for the parties’ mutual benefit,

  • but their interests are never fully aligned.

5

slide-6
SLIDE 6
  • A collaborator today can be a competitor tomorrow.

The collaboration conundrum

  • A collaborator today can be a competitor tomorrow.

6

slide-7
SLIDE 7

The risk

18 16 14 12 4 10 8 6 2

2 0 1 3 2 0 1 3

MAY JUN JUL AUG SEP OCT NOV DEC

2 0 1 4 2 0 1 4

JAN FEB MAR APR MAY JUN JUL AUG SEP OCT NOV DEC

2 0 1 5 2 0 1 5

JAN FEB MAR APR MAY JUN JUL

7

slide-8
SLIDE 8

The risk

18 16 14 12 10 8 6 4 2

2 0 1 3 2 0 1 3

MAY JUN JUL AUG SEP OCT NOV DEC

2 0 1 4 2 0 1 4

JAN FEB MAR APR MAY JUN JUL AUG SEP OCT NOV DEC

2 0 1 5 2 0 1 5

JAN FEB MAR APR MAY JUN JUL

8

slide-9
SLIDE 9
  • rock the boat
  • achieve clarity

Strategies to deal with the conundrum

  • limit access
  • don’t share what you can’t afford to lose

9

slide-10
SLIDE 10
  • 1. The collaboration conundrum
  • 2. The Tekmira case: a cautionary tale

Outline

  • 3. Best practices for drafting specific provisions

10

slide-11
SLIDE 11

The Tekmira case: a cautionary tale

  • drug development collaboration
  • collaborators became competitors
  • lawsuit over IP ownership

11

slide-12
SLIDE 12
  • 1. The collaboration conundrum
  • 2. The Tekmira case: a cautionary tale

Outline

  • 3. Best practices for drafting specific provisions

12

slide-13
SLIDE 13
  • confidentiality clauses
  • IP clauses

Best practices for specific provisions

  • license and sublicense rights
  • 13
slide-14
SLIDE 14
  • confidentiality clauses
  • IP clauses

Best practices for specific provisions

  • license and sublicense rights
  • 14
slide-15
SLIDE 15

Confidentiality clauses

15

slide-16
SLIDE 16

Confidentiality clauses: non-use

16

slide-17
SLIDE 17

Confidentiality clauses: non-disclosure

17

slide-18
SLIDE 18
  • Exceptions – they can swallow the rule.
  • Confidentiality clauses: exceptions

18

slide-19
SLIDE 19
  • known by receiving party prior to effective date
  • lawfully disclosed to receiving party by another
  • the information becomes published through no fault of

Standard exceptions

  • the information becomes published through no fault of

the receiving party

  • independently developed by receiving party without

reference to the confidential information

  • 19
slide-20
SLIDE 20

information can be disclosed if “reasonably necessary” to

Non-standard exceptions

information can be disclosed if “reasonably necessary” to conduct clinical trials or obtain regulatory approval

20

slide-21
SLIDE 21

information can be disclosed if “reasonably necessary” for

Non-standard exceptions

information can be disclosed if “reasonably necessary” for the prosecution or maintenance of patent rights

21

slide-22
SLIDE 22

information can be disclosed if “reasonably required” for a party to obtain financing or conduct discussions with development or commercialization partners, so long as

Non-standard exceptions

development or commercialization partners, so long as such third party recipients are bound by an obligation of confidentiality

22

slide-23
SLIDE 23

information can be disclosed if “reasonably required” for a party to obtain financing or conduct discussions with development or commercialization partners, so long as

Non-standard exceptions

development or commercialization partners, so long as such third party recipients are bound by an obligation of confidentiality

23

slide-24
SLIDE 24

information can be disclosed if “reasonably required” for a party to obtain financing or conduct discussions with development or commercialization partners, so long as

Non-standard exceptions

development or commercialization partners, so long as such third party recipients are bound by an obligation of confidentiality

  • or: “You must keep my information confidential

. . . . unless you can sell it.”

24

slide-25
SLIDE 25

information can be disclosed if “reasonably required” for a party to obtain financing or conduct discussions with development or commercialization partners, so long as

Non-standard exceptions

development or commercialization partners, so long as such third party recipients are bound by an obligation of confidentiality

25

slide-26
SLIDE 26

information can be disclosed if “reasonably required” to

Non-standard exceptions

information can be disclosed if “reasonably required” to comply with applicable laws or regulations or legal process

26

slide-27
SLIDE 27

Notice and consent

27

slide-28
SLIDE 28

Limitations on disclosures

28

slide-29
SLIDE 29
  • limit disclosure to specific persons named in advance in writing
  • limit disclosure to specific purpose
  • require employees to personally execute NDA

Advanced confidentiality protection

  • require employees to personally execute NDA
  • require encryption and passwords for electronic files
  • require maintenance of access log and audit rights
  • prohibit any disclosure to third parties
  • always require advance notice & written consent

29

slide-30
SLIDE 30
  • confidentiality clauses
  • IP clauses

Best practices for specific provisions

  • license and sublicense rights
  • 30
slide-31
SLIDE 31
  • example provision

IP Clauses

31

slide-32
SLIDE 32
  • ownership – keep with original owner
  • how to define

Preexisting IP

  • right to use / license / sublicense

32

slide-33
SLIDE 33

when one party uses the information it learns from the collaboration as a starting point for new inventions

Improvements / derivatives

33

slide-34
SLIDE 34

Patent thicket

34

Your Your IP IP Your Your IP IP

slide-35
SLIDE 35

Patent thicket

35

Your Your IP IP Your Your IP IP

slide-36
SLIDE 36
  • threshold issue of whether to allow improvements
  • if you decide to allow improvements
  • specify purposes for which improvements can be made

Improvements / derivatives

  • specify purposes for which improvements can be made
  • address ownership
  • address ability to use, license, sublicense improvements

36

slide-37
SLIDE 37
  • defining collaboration IP
  • consider periodic updates to ensure parties are on same page
  • consider streamlined arbitration process to resolve disputes

Collaboration IP

  • consider streamlined arbitration process to resolve disputes
  • ownership of collaboration IP
  • rights to use, license, sublicense collaboration IP

37

slide-38
SLIDE 38

Right to patent

38 p 35 p 35

slide-39
SLIDE 39
  • preexisting IP
  • improvements

Right to patent

  • collaboration IP
  • notice & consent

39

slide-40
SLIDE 40
  • confidentiality clauses
  • IP clauses

Best practices for specific provisions

  • license and sublicense rights
  • 40
slide-41
SLIDE 41

Ownership Ownership

Ownership vs. licensing

41

License License

slide-42
SLIDE 42

clarify what is being licensed

  • patents
  • know-how

License grant

  • know-how
  • other rights
  • other information

42

slide-43
SLIDE 43

clarify scope of license

  • right to use, commercialize, manufacture, etc.
  • for any purpose, or only purpose of collaboration?

License grant

  • for any purpose, or only purpose of collaboration?
  • for any use?
  • for whose benefit?

43

slide-44
SLIDE 44

decide whether to allow sublicense rights or not

  • you may lose control over your IP

Sublicense rights

  • you may not be getting an appropriate benefit
  • you may lose business opportunities

44

slide-45
SLIDE 45

if you decide to grant sublicense rights

  • get the appropriate benefit of any sublicense

Sublicense rights

  • get the appropriate benefit of any sublicense
  • protect your information

45

slide-46
SLIDE 46
  • rock the boat
  • clarity and transparency

Best practices

  • limit access of what is shared
  • don’t share what you can’t afford to lose

46

slide-47
SLIDE 47
  • For copies of this presentation
  • and MCLE forms, please visit:

Thank you

  • http://www.orrick.com/Events-and-

Publications/Pages/It-Is-Not-Just-Boilerplate.aspx

47

slide-48
SLIDE 48

Elizabeth A. Howard, Ph.D.

Thank you

Michael C. Spillner

ehoward@orrick.com (650) 614-7316 mspillner@orrick.com (650) 614-7395

48